Perkins Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$551K Hold
8,441
0.55% 45
2025
Q1
$565K Hold
8,441
0.6% 48
2024
Q4
$467K Sell
8,441
-750
-8% -$41.5K 0.41% 60
2024
Q3
$548K Hold
9,191
0.51% 55
2024
Q2
$585K Hold
9,191
0.55% 56
2024
Q1
$635K Hold
9,191
0.53% 57
2023
Q4
$507K Hold
9,191
0.43% 61
2023
Q3
$534K Hold
9,191
0.53% 53
2023
Q2
$495K Buy
9,191
+665
+8% +$35.8K 0.43% 59
2023
Q1
$339K Hold
8,526
0.32% 69
2022
Q4
$343K Hold
8,526
0.36% 66
2022
Q3
$274K Sell
8,526
-900
-10% -$28.9K 0.31% 73
2022
Q2
$280K Hold
9,426
0.29% 72
2022
Q1
$265K Sell
9,426
-1,500
-14% -$42.2K 0.22% 83
2021
Q4
$503K Sell
10,926
-3,150
-22% -$145K 0.34% 73
2021
Q3
$462K Hold
14,076
0.29% 74
2021
Q2
$493K Sell
14,076
-590
-4% -$20.7K 0.28% 76
2021
Q1
$530K Buy
+14,666
New +$530K 0.31% 72
2020
Q1
Sell
-11,491
Closed -$709K 109
2019
Q4
$709K Sell
11,491
-11,292
-50% -$697K 0.64% 54
2019
Q3
$1.66M Sell
22,783
-7,017
-24% -$511K 1.43% 24
2019
Q2
$2.45M Sell
29,800
-2,750
-8% -$226K 1.72% 19
2019
Q1
$2.3M Sell
32,550
-150
-0.5% -$10.6K 1.51% 18
2018
Q4
$1.47M Sell
32,700
-250
-0.8% -$11.3K 1.14% 24
2018
Q3
$1.86M Buy
32,950
+1,950
+6% +$110K 1.12% 27
2018
Q2
$2.07M Buy
31,000
+4,000
+15% +$267K 1.48% 12
2018
Q1
$1.57M Hold
27,000
1.42% 15
2017
Q4
$1.74M Buy
27,000
+7,200
+36% +$464K 1.67% 13
2017
Q3
$1.04M Sell
19,800
-1,750
-8% -$91.8K 1.09% 31
2017
Q2
$1.01M Sell
21,550
-600
-3% -$28.1K 1.12% 25
2017
Q1
$1.1M Buy
+22,150
New +$1.1M 1.13% 26